KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Common Equity (2018 - 2021)

BioNTech SE's Common Equity history spans 4 years, with the latest figure at $13.6 billion for Q4 2021.

  • For Q4 2021, Common Equity rose 731.88% year-over-year to $13.6 billion; the TTM value through Dec 2021 reached $13.6 billion, up 731.88%, while the annual FY2021 figure was $13.6 billion, 731.88% up from the prior year.
  • Common Equity for Q4 2021 was $13.6 billion at BioNTech SE, up from $1.6 billion in the prior quarter.
  • Across five years, Common Equity topped out at $13.6 billion in Q4 2021 and bottomed at $304.8 million in Q4 2018.
  • The 4-year median for Common Equity is $1.1 billion (2020), against an average of $4.0 billion.
  • The largest annual shift saw Common Equity surged 79.24% in 2019 before it skyrocketed 731.88% in 2021.
  • A 4-year view of Common Equity shows it stood at $304.8 million in 2018, then soared by 79.24% to $546.2 million in 2019, then surged by 199.42% to $1.6 billion in 2020, then surged by 731.88% to $13.6 billion in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Common Equity are $13.6 billion (Q4 2021), $1.6 billion (Q4 2020), and $546.2 million (Q4 2019).